BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Policy

  Cerus Completes CE Mark Submission for INTERCEPT Red Blood Cells

  Cerus today announced that it has filed for CE Mark registration for the Company’s INTERCEPT red blood cell system.

  December 18, 2018

   · 

  4 min read
• Policy

  Transplants provide better outcomes than dialysis for end-stage kidney disease

  New data from the Canadian Institute for Health Information (CIHI) highlights the significant difference between dialysis and transplant outcomes for those being treated for end-stage kidney disease (ESKD).

  December 18, 2018

   · 

  4 min read
• Business

  Another Record Year for ZEISS

  In fiscal year 2017/18 (ended on 30 September 2018), the company achieved record-breaking revenue and earnings

  December 18, 2018

   · 

  2 min read